Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

NCT00452881 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

151

Enrollment

OTHER_GOV

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: gemcitabine
DRUG: Oxaliplatin
DRUG: Cisplatin

Sponsor

National Cancer Center, Korea